Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without Eptifibatide

✍ Scribed by Jeffrey S. Mandak; James C. Blankenship; Laura H. Gardner; Scott D. Berkowitz; Frank V. Aguirre; Kristina N. Sigmon; Gerald C. Timmis; Ian C. Gilchrist; Michael McIvor; Jon Resar; Bonnie H. Weiner; Barry S. George; J.David Talley; A.Michael Lincoff; James E. Tcheng; Robert M. Califf; Eric J. Topol

• Book ID: 118588209
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 75 KB
• Volume: 31
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(98)00130-2